Brown Capital Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,260,466
Closed -$310M 129
2022
Q3
$310M Sell
1,260,466
-1,993
-0.2% -$538K 4.34% 8
2022
Q2
$312M Sell
1,262,459
-116,346
-8% -$31.4M 4.18% 7
2022
Q1
$457M Sell
1,378,805
-34,013
-2% -$10.5M 4.55% 7
2021
Q4
$507M Sell
1,412,818
-17,686
-1% -$5.98M 4.2% 10
2021
Q3
$466M Sell
1,430,504
-110,968
-7% -$37.6M 3.81% 10
2021
Q2
$481M Sell
1,541,472
-60,077
-4% -$18.4M 3.65% 13
2021
Q1
$510M Sell
1,601,549
-17,299
-1% -$5.54M 3.8% 9
2020
Q4
$525M Buy
1,618,848
+767
+0% +$212K 3.63% 10
2020
Q3
$448M Sell
1,618,081
-12,291
-0.8% -$3.54M 3.72% 11
2020
Q2
$394M Sell
1,630,372
-11,085
-0.7% -$2.23M 3.39% 13
2020
Q1
$238M Buy
1,641,457
+11,865
+0.7% +$1.97M 2.76% 16
2019
Q4
$278M Buy
1,629,592
+3,050
+0.2% +$565K 2.66% 18
2019
Q3
$289M Buy
1,626,542
+268,066
+20% +$57.9M 2.81% 18
2019
Q2
$354M Buy
1,358,476
+125,857
+10% +$33.4M 3.36% 15
2019
Q1
$352M Sell
1,232,619
-8,526
-0.7% -$2.83M 3.56% 12
2018
Q4
$403M Sell
1,241,145
-22,066
-2% -$7.67M 4.85% 4
2018
Q3
$568M Buy
1,263,211
+3,435
+0.3% +$1.35M 5.16% 4
2018
Q2
$515M Sell
1,259,776
-149,644
-11% -$54.2M 5.29% 1
2018
Q1
$410M Sell
1,409,420
-20,727
-1% -$5.25M 4.66% 7
2017
Q4
$268M Buy
1,430,147
+43,076
+3% +$8.04M 3.25% 14
2017
Q3
$234M Sell
1,387,071
-7,406
-0.5% -$1.12M 2.85% 17
2017
Q2
$200M Buy
1,394,477
+478,777
+52% +$64.3M 2.45% 19
2017
Q1
$115M Buy
915,700
+213,889
+30% +$24.8M 1.53% 25
2016
Q4
$79.1M Buy
701,811
+97,847
+16% +$11.3M 1.15% 29
2016
Q3
$77.7M Buy
603,964
+10,005
+2% +$1.2M 1.14% 26
2016
Q2
$64.9M Buy
593,959
+135,436
+30% +$13.5M 1.03% 27
2016
Q1
$43.5M Buy
+458,523
New +$38.7M 0.72% 30

Other funds holding ABMD

Brown Capital Management's ABMD Position: Q4 2022 in Review

Brown Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,260,466 shares — an estimated $310M sold.

Brown Capital Management first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $568M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Brown Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Brown Capital Management sold 1,260,466 Abiomed Inc shares in Q4 2022, an estimated $310M.
  • Brown Capital Management first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Brown Capital Management's Abiomed Inc position peaked at $568M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Brown Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.